Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS · Delayed Price · Currency is USD
0.0101
+0.0001 (1.00%)
Apr 16, 2026, 1:07 PM EST
Emmaus Life Sciences Market Cap
Emmaus Life Sciences has a market cap or net worth of $708.9 thousand as of April 17, 2026. Its market cap has increased by 2,119.96% in one year.
Market Cap
708.90K
Enterprise Value
31.14M
Revenue
12.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since July 18, 2019, Emmaus Life Sciences's market cap has decreased from 353.30M to 708.90K, a decrease of -99.80%. That is a compound annual growth rate of -60.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 701.88K | -15.46% |
| Dec 31, 2025 | 830.25K | 52.94% |
| Dec 31, 2024 | 542.86K | -91.23% |
| Dec 29, 2023 | 6.19M | -52.02% |
| Dec 30, 2022 | 12.90M | -84.34% |
| Dec 31, 2021 | 82.35M | 36.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exousia Pro | 836.92K |
| SQZ Biotechnologies Company | 707.79K |
| Halberd | 698.73K |
| Scorpius Holdings | 611.43K |
| Aibotics | 593.30K |
| Windtree Therapeutics | 589.34K |
| Bio-Path Holdings | 582.95K |
| Hepion Pharmaceuticals | 557.78K |